Gujarat Themis Biosyn (NSE:GUJTHEM) Dividends Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:GUJTHEM Gujarat Themis Biosyn Ltd NSE:GUJTHEM
67 GF Score
Price ₹351.25
GF Value ₹351.41
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Gujarat Themis Biosyn Dividends Received?

Dividends Received only applicable to companies reporting Cash Flow from Operations in direct method.

NSE:GUJTHEM
67GF Score
Gujarat Themis Biosyn Ltd NSE:GUJTHEM
Dividends Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Gujarat Themis Biosyn (NSE:GUJTHEM) Overvalued in 2026?

Based on GuruFocus' analysis, Gujarat Themis Biosyn stock appears to be undervalued. The current stock price of ₹351.25 is trading 0% below its estimated GF Value™ of ₹351.41. GuruFocus considers Gujarat Themis Biosyn to be Fairly Valued.

Key valuation signals for NSE:GUJTHEM:

  • Dividends Received:
  • GF Value™: ₹351.41 vs. price of ₹351.25 (0% below fair value)
  • GF Score™: 67/100 with 6 warning signs

No single metric tells the full story. See the NSE:GUJTHEM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Gujarat Themis Biosyn Business Description

Other Exchanges 506879:India
Address S.V Road, Themis House, 11/12 Udyog Nagar, Goregaon (West), Mumbai, MH, IND, 400104
Gujarat Themis Biosyn Ltd is engaged in manufacturing, exporting, and selling of bulk drugs on a job-work basis. The company operates in one segment which is pharmaceuticals. Its products include Rifamycin-S, which is an intermediate for Rifampicin for the treatment of tuberculosis (TB), and Lovastatin.
67GF Score

Get the complete analysis for NSE:GUJTHEM

Dividends Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹351.25
Price
₹351.41
GF Value